Sabby Management, LLC Intra Cellular Therapies, Inc. Transaction History

Sabby Management, LLC

  • $130,000
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$30.8 - $39.51 $1.08 Million - $1.38 Million
-35,000 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$23.34 - $32.22 $1.87 Million - $2.58 Million
-80,000 Reduced 69.57%
35,000 $1.11 Million
Q3 2020

Nov 16, 2020
BUY
$17.61 - $31.86 $2.03 Million - $3.66 Million
115,000 New
115,000 $2.95 Million

Others Institutions Holding ITCI

# of Institutions
377
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.07B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email